Emulsion for ultrasound ablation surgery
US12251451B2 · kind B2 · utility
0Cited by
1References
13Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 14, 2019 |
| Grant date | Mar 18, 2025 |
| Priority date | — |
| Expiry date | Oct 27, 2040 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present description relates to an injectable emulsion comprising an amphiphilic compound, a first phase comprising droplets including at least one perfluorocarbon compound and a second phase, which is aqueous. The droplets have a diameter d4,3 of between 0.5 pm and 5.5 pm, and the at least one perfluorocarbon compound has a boiling point above 100° C. The present description also relates to methods comprising administering such an injectable emulsion in, for example, ultrasound ablation surgery (FIG. 3).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.